{"id":1242,"date":"2024-03-13T16:42:08","date_gmt":"2024-03-13T07:42:08","guid":{"rendered":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/?page_id=1242"},"modified":"2025-08-13T13:23:28","modified_gmt":"2025-08-13T04:23:28","slug":"publications2024","status":"publish","type":"page","link":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/publications\/publications2024\/","title":{"rendered":"2024"},"content":{"rendered":"

\u7dcf\u8aac\u30fb\u8457\u66f8<\/strong><\/p>\n

    \n
  1. \u6a0b\u7530\u4eac\u5b50<\/u>: \u6b6f\u5b66\u751f\u306e\u305f\u3081\u306e\u57fa\u790e\u75c5\u7406\u5b66, Chapter8 \u67d3\u8272\u4f53\u30fb\u907a\u4f1d\u5b50\u304a\u3088\u3073\u767a\u751f\u306e\u7570\u5e38, \u201c\u67d3\u8272\u4f53\u30fb\u907a\u4f1d\u5b50\u306e\u57fa\u672c\u201d, \u533b\u6b6f\u85ac\u51fa\u7248, 170-175, 2024\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n<\/ol>\n

     <\/p>\n

    \u82f1\u6587\u7dcf\u8aac<\/strong><\/p>\n

      \n
    1. Hida K<\/u>*, <\/u>Maishi N, Matsuda A, Yu L: Beyond starving cancer, antiangiogenic therapy, J Med Ultrasonic<\/em><\/strong>, 2024; 51(4). doi:10.1007\/s10396-023-01310-1<\/li>\n
    2. Takakura Y, Hanayama R, Akiyoshi K, Futaki S, Hida K, Ichiki T, IshiiWatabe A,Kuroda M, Maki K, Miura Y, Okada Y, Seo N, Takeuchi T, Yamaguchi T, Yoshioka Y: Quality and Safety Considerations for Therapeutic Products Based on ExtracellularVesicles, Pharmaceutical Research, 2024, doi.org\/10.1007\/s11095-024-03757-4<\/li>\n<\/ol>\n

      \u82f1\u8a9e\u8ad6\u6587<\/strong><\/p>\n

        \n
      1. Jia Z, Maishi N, Takekawa H, Yanagawa Matsuda A, Nakade T, Nakamura T, Harashima H, Hida Y, <\/span>Hida K<\/span>*<\/span>: Targeting Tumor Endothelial Cells by EGCG Using Specific Liposome Delivery System Inhibits Vascular Inflammation and Thrombosis, <\/span>Cancer Medicine<\/i><\/b>. 2024 Dec 04<\/span>. <\/b>13(23): e70462. Doi: org\/10.1002\/cam4.70462<\/span><\/li>\n
      2. Baba S,Kawasaki T,\u00a0Hirano S, \u00a0Nakamura T,\u00a0Asano T,\u00a0Okazaki R, Yoshida K, Kawase T, \u00a0\u00a0Kurahara H, \u00a0Oi H, \u00a0\u00a0Yokoyama M, Kita J,\u00a0\u00a0Imura J, \u00a0Kinoshita K,\u00a0Kondo S, Okada M,\u00a0Satake T,\u00a0 Shimoda\u00a0Igawa Y, Yoshida T,\u00a0Yamaguchi H, Ando Y,\u00a0Mizunuma M,\u00a0Ichikawa Y,\u00a0Hida K\u00a0, Nishihara H,\u00a0Kato Y: A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control study, e Clinical Medicine<\/em><\/strong>.<\/em> 2024 Nov 11<\/li>\n
      3. Lee JW, Mizuno K, Watanabe H, Lee IH, Tsumita T, Hida K, Yawaka Y, Kitagawa Y,Hasebe A, Iimura T, Kong SW: Enhanced phagocytosis associated with multinucleated microglia via Pyk2 inhibition in an acute \u03b2-amyloid infusion model, J Neuroinflammation. 2024 Aug 6;21(1):196. doi:10.1186\/s12974-024-03192-7.<\/li>\n
      4. Miho Tokumasu, Mikako Nishida, Weiyang Zhao, Ruoyu Chao, Natsumi Imano ,Nahoko Yamashita, Kyoko Hida, Hisamichi Naitoc and Heiichiro Udono: Metformin synergizes with PD-1 blockade to promote normalization of tumor vessels via CD8T cells and IFN\u03b3, PNAS, e2404778121, doi.org\/10.1073\/pnas.2404778121<\/li>\n<\/ol>\n

         <\/p>\n

        \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u30fb\u62db\u5f85\u8b1b\u6f14<\/strong><\/p>\n

          \n
        1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c66\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a \u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u30e9\u30a4\u30aa\u30f3\u5b66\u8853\u8cde\u53d7\u8cde\u8b1b\u6f14, \u201c\u304c\u3093\u95a2\u9023\u8840\u6813\u75c7\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u5f79\u5272\u306e\u89e3\u660e\u201d, 2024.11.3\uff08\u9577\u5d0e)<\/li>\n
        2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c66\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u30b7\u30f3\u30dd\u30b8\u30a6\u30e05, \u201d \u9ad8\u8ee2\u79fb\u6027\u816b\u760d\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306e\u7570\u5e38\u6027\u7372\u5f97\u201d,2024.11.3\uff08\u9577\u5d0e\uff09<\/li>\n
        3. \u6a0b\u7530\u4eac\u5b50<\/u>: \u7b2c83\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u201cTumor endothelial cells and cancer-associated thrombosis\u201d, 2024.9.21\uff08\u798f\u5ca1\uff09<\/li>\n
        4. Hida K<\/span>: 2024 KSBC-Hokkaido University Joint Symposium on Bioconvergence, \u201cThe role of tumor\u00a0endothelial cells\u00a0in cancer metastasis\u201d, 2024,8,28, Sapporo<\/span><\/li>\n
        5. Li Yu: 2024 KSBC-Hokkaido University Joint Symposium on Bioconvergence, \u201cTumor endothelial cells\u00a0and cancer-associated thrombosis\u201d, 2024,8,28, Sapporo<\/span><\/li>\n
        6. Yu Li, Kyoko Hida<\/u>\uff1aVascular inflammation and tumor metastasis\uff0c\u7b2c33\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a. 2024.6.27(\u5948\u826f)<\/li>\n
        7. \u6a0b\u7530\u4eac\u5b50<\/span>: \u7b2c9\u56de\u8840\u7ba1\u751f\u7269\u533b\u5b66\u4f1a\u82e5\u624b\u7814\u7a76\u4f1a, \u201c\u304c\u3093\u304b\u3089\u611f\u67d3\u75c7\u307e\u3067\uff1a\u816b\u760d\u8840\u7ba1\u7814\u7a76\u304c\u5c0e\u304f\u65b0\u305f\u306a\u767a\u898b\u201d, 2024.6.14,\uff08\u6771\u4eac\uff09<\/span><\/li>\n<\/ol>\n

           <\/p>\n

          \u30bb\u30df\u30ca\u30fc\u7b49\u306e\u62db\u5f85\u8b1b\u6f14\u30fb\u5b66\u4f1a\u4ee5\u5916<\/strong><\/p>\n

            \n
          1. \u6a0b\u7530\u4eac\u5b50<\/span>: \u7b2c19\u56de\u5148\u7aef\u6b6f\u5b66\u30b9\u30af\u30fc\u30eb2024\u6559\u80b2\u8b1b\u6f14, \u201c\u8840\u7ba1\u7814\u7a76\u306e\u5148\u306b\u898b\u3048\u308b\u3082\u306e\u201d2024.8.23\uff08\u6771\u4eac\uff09<\/span><\/li>\n<\/ol>\n

             <\/p>\n

            \u56fd\u969b\u5b66\u4f1a\u767a\u8868<\/strong><\/p>\n

              \n
            1. Li Yu, Yuying Hong, Nako Maishi, Aya Matsuda, Yasuhiro Hida, Akira Hasebe, Kyoko Hida<\/u>\uff1aOral bacterium Streptococcus mutans promotes tumor metastasis through thrombosis formation. poster. International Vascular Biology Meeting (IVBM2024). 2024.7.2 (Amsterdam)<\/li>\n
            2. Yu L, Maishi N, Hong Y, Akahori E, Hasebe A, Takeda R, Matsuda A, Hida Y, <\/span>Hida K<\/span>: The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation and thrombosis, poster. The 42nd Sapporo International Cancer Symposium, 2024.6.8, Sapporo<\/span><\/li>\n<\/ol>\n

               <\/p>\n

              \u56fd\u5185\u5b66\u4f1a\u767a\u8868<\/strong><\/p>\n

                \n
              1. \u685c\u4e95\u512a\u5f25,\u9593\u77f3\u5948\u6e56,\u85e4\u5ca1\u5bb9\u4e00\u6717,\u5927\u5834\u96c4\u4ecb,\u6b66\u7530\u907c,\u4f50\u3005\u6728\u9053\u4ec1,\u5927\u5834\u9756\u5b50,\u6a0b\u7530\u6cf0\u6d69,\u6fa4\u6d0b\u6587,\u6a0b\u7530\u4eac\u5b50\uff1a\u52a0\u9f62\u306b\u4f34\u3046\u8840\u7ba1\u5185\u76ae\u7d30\u80deSARS-CoV-2\u611f\u67d3\u5897\u5f37\u30e1\u30ab\u30cb\u30ba\u30e0\u306e\u89e3\u6790,\u7b2c32\u56de\u65e5\u672c\u8840\u7ba1\u751f\u7269\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2024.12.7\uff08\u6771\u4eac\uff09<\/li>\n
              2. Jia Zi,\u9593\u77f3\u5948\u6e56,\u677e\u7530\u5f69,\u5343\u7530\u5065\u535a,\u4e2d\u5cf6\u5b5d\u5e73,\u6a0b\u7530\u6cf0\u6d69,\u5c0f\u5ddd\u7f8e\u9999\u5b50,\u6a0b\u7530\u4eac\u5b50\uff1aAngiogenic inhibitor pre-administration improves the therapeutic effects of Near-infrared photoimmunotherapy, \u7b2c57\u56de\u5317\u6d77\u9053\u75c5\u7406\u8ac7\u8a71\u4f1a, 2024.10.12\uff08\u65ed\u5ddd\uff09<\/li>\n
              3. \u8d64\u5800\u6c38\u502b\u9999, YuLi, \u9593\u77f3\u5948\u6e56, \u677e\u7530\u5f69, \u9577\u8c37\u90e8\u6643, \u5bae\u672c\u90c1\u4e5f,\u00a0\u00a0\u6a0b\u7530\u4eac\u5b50\uff1aPorphyromonas gingivalis\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u5f62\u8cea\u5909\u5316\u306f\uff0c\u8840\u7ba1\u900f\u904e\u6027\u4ea2\u9032\u3092\u8a98\u5c0e\u3057\u816b\u760d\u8ee2\u79fb\u3092\u4fc3\u9032\u3059\u308b, \u7b2c57\u56de\u5317\u6d77\u9053\u75c5\u7406\u8ac7\u8a71\u4f1a, 2024.10.12\uff08\u65ed\u5ddd\uff09<\/li>\n
              4. \u5b97\u7247\u52c7\u53f2, \u677e\u7530\u5f69, \u9593\u77f3\u5948\u6e56, \u5bae\u672c\u90c1\u4e5f, \u6a0b\u7530\u6cf0\u6d69, \u6a0b\u7530\u4eac\u5b50\uff1a\u03b2\u906e\u65ad\u85ac\u306e\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u3078\u306e\u4f5c\u7528\u89e3\u6790\u3068\u304c\u3093\u8ee2\u79fb\u3078\u306e\u5f71\u97ff, \u7b2c57\u56de\u5317\u6d77\u9053\u75c5\u7406\u8ac7\u8a71\u4f1a, 2024.10.12\uff08\u65ed\u5ddd\uff09<\/li>\n
              5. Yu L, Hong Y, Lin L, Maishi N, Matsuda A, Dawood RIH, Sun W, Hida Y, Sato M\uff0cSato Y, Hida K: Biglycan in TEC promotes cancer-associated thrombosis formation, \u7b2c129\u56de\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a, 2024.9.14\uff08\u672d\u5e4c\uff09<\/li>\n
              6. \u6d2a\u8aed\u7469\uff0c\u4f59\u9e97 \uff0c\u9ad8\u6a4b\u90c1\u5b50 \uff0c\u9593\u77f3\u5948\u6e56 \uff0c\u677e\u7530\u3000\u5f69 \uff0c\u6a0b\u7530\u6cf0\u6d69 \uff0c\u5bae\u672c\u90c1\u4e5f \uff0c \u6a0b\u7530\u4eac\u5b50: Comparison miRNA in tumor endothelial cells of high and low metastatic tumors, \u7b2c129\u56de\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a, 2024.9.14\uff08\u672d\u5e4c\uff09<\/li>\n
              7. \u4f50\u85e4\u7950\u9ebb\uff0c\u685c\u4e95\u512a\u5f25 \uff0c\u624b\u4ee3\u6728\u5b5d\u4ec1 \uff0c\u9593\u77f3\u5948\u6e56 \uff0c\u4f59\u9e97 \uff0c\u677e\u7530\u5f69 \uff0c\u698a\u539f\u7d14 \uff0c \u4eca\u91ce\u3000\u54f2 \uff0c\u6a0b\u7530\u6cf0\u6d69 \uff0c\u6a0b\u7530\u4eac\u5b50\uff1a\u5316\u5b66\u7642\u6cd5\u8a98\u5c0e\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u8001\u5316\u304c\u3082\u305f\u3089\u3059\u514d\u75ab\u5fae\u5c0f\u74b0\u5883\u3078\u306e\u5f71\u97ff, \u7b2c129\u56de\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a, 2024.9.14\uff08\u672d\u5e4c\uff09<\/li>\n
              8. \u685c\u4e95\u512a\u5f25, \u9593\u77f3\u5948\u6e56\uff0c\u85e4\u5ca1\u5bb9\u4e00\u6717, \u5927\u5834\u96c4\u4ecb\uff0c\u6b66\u7530\u3000\u907c\uff0c\u4f50\u3005\u6728\u9053\u4ec1\uff0c\u5927\u5834\u9756\u5b50\uff0c\u6a0b\u7530\u6cf0\u6d69,\u3000\u6fa4\u3000\u6d0b\u6587\uff0c<\/span>\u6a0b\u7530\u4eac\u5b50<\/span>: \u52a0\u9f62\u306b\u4f34\u3046\u8840\u7ba1\u5185\u76ae\u7d30\u80de SARS-CoV-\u611f\u67d3\u5897\u5f37\u30e1\u30ab\u30cb\u30ba\u30e0\u306e\u89e3\u6790, \u53e3\u6f14, \u7b2c19\u56de\u5148\u7aef\u6b6f\u5b66\u30b9\u30af\u30fc\u30eb2024, 2024.8.23\uff08\u6771\u4eac\uff09\u512a\u79c0\u8cde\u53d7\u8cde<\/span><\/li>\n
              9. \u6a0b\u7530\u4eac\u5b50, \u9593\u77f3\u5948\u6e56, \u685c\u4e95\u512a\u5f25, \u4f0a\u85e4 \u822a, \u624b\u4ee3\u6728\u5b5d\u4ec1, \u6b66\u7530 \u907c, \u6a0b\u7530\u6cf0\u6d69, \u7a4d\u7530\u5353\u4e5f,\u677e\u7530 \u5f69, \u5c04\u5834\u667a\u5927, \u5185\u85e4\u5c1a\u9053, \u9ad8\u5c71\u548c\u96c4, \u4f50\u3005\u6728\u9053\u4ec1, \u5927\u5834\u9756\u5b50, \u6fa4\u3000\u6d0b\u6587:
                \nSARS-CoV-2\u611f\u67d3\u9577\u671f\u7d4c\u904e\u5f8c\u306e\u75c5\u614b\u306b\u53ca\u307c\u3059\u52a0\u9f62\u306e\u5f71\u97ff, \u53e3\u6f14, \u7b2c2\u56de\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u7814\u7a76\u96c6\u4f1a, 2024.8.4\uff08\u6771\u4eac\uff09<\/li>\n
              10. \u685c\u4e95\u512a\u5f25, \u9593\u77f3\u5948\u6e56, \u85e4\u5ca1\u5bb9\u4e00\u6717, \u5927\u5834\u96c4\u4ecb, \u4f50\u3005\u6728\u9053\u4ec1, \u5927\u5834\u9756\u5b50, \u6a0b\u7530\u6cf0\u6d69, \u6fa4 \u6d0b\u6587, \u6a0b\u7530\u4eac\u5b50: \u8840\u7ba1\u306e\u52a0\u9f62\u5909\u5316\u304c\u3082\u305f\u3089\u3059SARS-CoV-2\u53d6\u308a\u8fbc\u307f\u5897\u52a0\u306e\u30e1\u30ab\u30cb\u30ba\u30e0,\u53e3\u6f14, \u7b2c2\u56de\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u7814\u7a76\u96c6\u4f1a, 2024.8.2-2024.8.4\uff08\u6771\u4eac\uff09<\/li>\n
              11. \u677e\u7530\u3000\u5f69\uff0c\u5317\u6751\u54f2\u4e5f\uff0c\u5409\u5ddd\u548c\u4eba\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u6a0b\u7530\u4eac\u5b50: \u820c\u4e0b\u817a\u306b\u767a\u751f\u3057\u305f\u7a00\u306a\u817a\u623f\u7d30\u80de\u764c\u306e\u4e00\u4f8b,\u30dd\u30b9\u30bf\u30fc, \u7b2c35\u56de\u65e5\u672c\u81e8\u5e8a\u53e3\u8154\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a,2024,7,30\uff0d2024.8.1\uff08\u65b0\u6f5f\uff09<\/li>\n
              12. \u685c\u4e95\u512a\u5f25\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u677e\u7530\u3000\u5f69\uff0c\u6b66\u7530\u3000\u907c\uff0c\u4f0a\u85e4\u3000\u822a\uff0c\u6a0b\u7530\u4eac\u5b50: \u52a0\u9f62\u306b\u4f34\u3046\u8840\u7ba1\u5185\u76ae\u7d30\u80deSARS-CoV-2\u611f\u67d3\u5897\u5f37\u30e1\u30ab\u30cb\u30ba\u30e0\u306e\u89e3\u6790, \u30dd\u30b9\u30bf\u30fc. \u7b2c35\u56de\u65e5\u672c\u81e8\u5e8a\u53e3\u8154\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a, 2024,7,30\uff0d2024.8.1\uff08\u65b0\u6f5f\uff09\u512a\u79c0\u30dd\u30b9\u30bf\u30fc\u8cde\u53d7\u8cde<\/li>\n
              13. \u4f59 \u9e97, \u9593\u77f3 \u5948\u6e56, \u677e\u7530 \u5f69, <\/span>\u6a0b\u7530 \u4eac\u5b50<\/span>: \u8840\u7ba1\u708e\u75c7\u306b\u3088\u308b\u304c\u3093\u306e\u8ee2\u79fb\u4fc3\u9032, \u53e3\u6f14, \u7b2c78\u56de\u65e5\u672c\u53e3\u8154\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2024.7.19-21(\u6771\u4eac)<\/span><\/li>\n
              14. Li Yu: Vascular inflammation in inducing cancer-related thrombosis, \u53e3\u6f14, \u7b2c 6 \u56de \u53e3\u8154\u533b\u79d1\u5b66\u30d5\u30ed\u30f3\u30c6\u30a3\u30a2\u7814\u7a76\u4f1a, 2024.5.18\uff08\u672d\u5e4c\uff09<\/li>\n<\/ol>\n

                 <\/p>\n

                 <\/p>\n","protected":false},"excerpt":{"rendered":"

                \u7dcf\u8aac\u30fb\u8457\u66f8 \u6a0b\u7530\u4eac\u5b50: \u6b6f\u5b66\u751f\u306e\u305f\u3081\u306e\u57fa\u790e\u75c5\u7406\u5b66, Chapter8 \u67d3\u8272\u4f53\u30fb\u907a\u4f1d\u5b50\u304a\u3088\u3073\u767a\u751f\u306e\u7570\u5e38, \u201c\u67d3\u8272\u4f53\u30fb\u907a\u4f1d\u5b50\u306e\u57fa\u672c\u201d, \u533b\u6b6f\u85ac\u51fa\u7248, 170-175, 2024\uff08\u5206\u62c5\u57f7\u7b46\uff09   \u82f1\u6587\u7dcf\u8aac Hida K*, Maishi N, Matsuda A, Yu L: Beyond starving cancer, antiangiogenic therapy, J Med Ultra…\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"parent":18,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"publications.php","meta":{"footnotes":""},"class_list":["post-1242","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t